Ceribell (CBLL) Preferred Stock Liabilities (2023 - 2024)
Ceribell's (CBLL) quarterly Preferred Stock Liabilities came in at $147.4 million in Q3 2024, little changed on a YoY basis from $147.4 million in Q4 2023, and little changed quarter-over-quarter from $147.4 million in Q2 2024.
Powered by 
Analysis
Ceribell (CBLL) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends
Ceribell (CBLL) has reported Preferred Stock Liabilities for 2 consecutive years, with $147.4 million the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Preferred Stock Liabilities changed 0.0% year-over-year to $147.4 million; the trailing twelve-month figure through Sep 2024 stood at $147.4 million (changed 0.0% YoY), and the FY2023 full-year result was $147.4 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $147.4 million in Q3 2024 per CBLL's latest filing, from $147.4 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $147.4 million in Q3 2023 and bottomed at $147.4 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.54 Bn | 27.44 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.04 Bn | 3.66 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.59 Bn | 2.41 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.96 Bn | 1.84 Bn | 23.29 Mn | - |
| 6 | Ceribell | 928.74 Mn | 799.48 Mn | 25.94 Mn | - |
| 7 | QuidelOrtho | 866.04 Mn | 742.64 Mn | - | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | - |
| 9 | Prenetics Global | 339.99 Mn | 280.94 Mn | 30.20 Mn | - |
| 10 | CapsoVision | 318.60 Mn | 309.52 Mn | 1.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 147.41 Mn |
| Jun 30, 2024 | 147.41 Mn |
| Mar 31, 2024 | 147.41 Mn |
| Dec 31, 2023 | 147.41 Mn |
| Sep 30, 2023 | 147.41 Mn |